Kimberly Kraig Thompson Kraig Biocraft Laboratories, Inc (KBLB) insider trading activity

KBLB Quotes by TradingView

Kimberly Kraig Thompson is CEO & CFO of Kraig Biocraft Laboratories, Inc. Currently has a direct ownership of 202 Million shares of KBLB, which is worth approximately $16.1 Million. The most recent transaction as insider was on May 25, 2022, when has been sold 25,000 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 202M
0% 3M change
0% 12M change
Total Value Held $16.1 Million

Kimberly Kraig Thompson Transaction History

Date Transaction Value Shares Traded Shares Held Form
May 25 2022
SELL
Open market or private sale
-
25,000 Reduced 0.01%
202,769,824 Common Stock
May 24 2022
SELL
Open market or private sale
-
30,000 Reduced 0.01%
202,794,824 Common Stock
May 23 2022
SELL
Open market or private sale
-
20,000 Reduced 0.01%
202,824,824 Common Stock
May 20 2022
SELL
Open market or private sale
-
25,000 Reduced 0.01%
202,844,824 Common Stock
May 19 2022
SELL
Open market or private sale
-
15,048 Reduced 0.01%
202,869,824 Common Stock
May 18 2022
SELL
Open market or private sale
-
20,000 Reduced 0.01%
202,884,872 Common Stock
May 17 2022
SELL
Open market or private sale
-
20,000 Reduced 0.01%
202,904,872 Common Stock
May 13 2022
SELL
Open market or private sale
-
22,500 Reduced 0.01%
202,924,872 Common Stock
May 12 2022
SELL
Open market or private sale
-
20,000 Reduced 0.01%
202,947,372 Common Stock
May 11 2022
SELL
Open market or private sale
-
20,000 Reduced 0.01%
202,967,372 Common Stock
May 10 2022
SELL
Open market or private sale
-
10,000 Reduced 0.0%
202,987,372 Common Stock
May 06 2022
SELL
Open market or private sale
-
2,000 Reduced 0.0%
202,997,372 Common Stock
May 04 2022
SELL
Open market or private sale
-
11,400 Reduced 0.01%
202,999,372 Common Stock
May 03 2022
SELL
Open market or private sale
-
20,000 Reduced 0.01%
203,010,772 Common Stock
May 02 2022
SELL
Open market or private sale
-
12,000 Reduced 0.01%
203,030,772 Common Stock
Apr 29 2022
SELL
Open market or private sale
-
20,000 Reduced 0.01%
203,042,772 Common Stock
Apr 28 2022
SELL
Open market or private sale
-
194,795 Reduced 0.1%
203,062,772 Common Stock
Apr 27 2022
SELL
Open market or private sale
-
50,000 Reduced 0.02%
203,257,567 Common Stock
Apr 26 2022
SELL
Open market or private sale
-
50,044 Reduced 0.02%
203,307,567 Common Stock
Aug 18 2021
SELL
Open market or private sale
-
36,938 Reduced 0.02%
203,357,609 Common Stock
Aug 05 2021
SELL
Open market or private sale
-
36,000 Reduced 0.02%
203,394,547 Common Stock
Jul 29 2021
SELL
Open market or private sale
-
100,000 Reduced 0.05%
203,430,547 Common Stock
Jul 28 2021
SELL
Open market or private sale
-
110,000 Reduced 0.05%
203,530,547 Common Stock
Jul 23 2021
SELL
Open market or private sale
-
10,000 Reduced 0.0%
203,640,547 Common Stock
Jul 22 2021
SELL
Open market or private sale
-
10,000 Reduced 0.0%
203,650,547 Common Stock
KKT

Kimberly Kraig Thompson

CEO & CFO
Ann Arbor,, MI

Track Institutional and Insider Activities on KBLB

Follow Kraig Biocraft Laboratories, Inc and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells KBLB shares.

Notify only if

Insider Trading

Get notified when an Kraig Biocraft Laboratories, Inc insider buys or sells KBLB shares.

Notify only if

News

Receive news related to Kraig Biocraft Laboratories, Inc

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on KBLB